Management Team
Maria Lundberg has an M.Sc in Chemical Engineering from Lund. She is the Managing Director with 20+ years of experience in leading positions in the pharma industry. She has provided services to pharma customers throughout the main part of her career. Maria’s passion lies in building teams that achieve greater things together; with trust, empowerment and prestigelessness as her main values. Her experience from remotely leading teams in a global environment; in UK, France, Sweden, and India, will be of much importance in the SDS growth journey.
Anna Torrång has a BSc in Statistics from the University of Linköping, Sweden, and a long and broad experience (>25 years) in the pharmaceutical industry and epidemiological research at the Karolinska Institute in Stockholm. Within AstraZeneca, she worked as a Global Product Statistician in projects within neuroscience and as a Group Manager for Biostatisticians. Her primary expertise lies within clinical development, and the design and statistical analysis of clinical trials. Anna has worked at SDS since 2013, primarily as a senior biostatistical consultant in drug development and as the Director for SDS Biostatistics.
Maria joined SDS Life Science in Nov 2021 as Director of Clinical Project Management. She brings 20+ years of experience in the life science Industry, which gives her a broad understanding of the Drug Development process from clinical trial planning and execution in Phase I to Phase IV. Furthermore, Maria has experience from small academic studies and developing functional food and food supplements. She has multicultural knowledge from managing cross-functional teams in Sweden, India, China, and Indonesia. Maria’s passion is to support her team to deliver clinical projects that in the end improve patients´ quality of life. Maria holds an MSc in Pharmacy from Uppsala University.
Erika Spens started working at SDS Life Science in 2021 as director for regulatory affairs. Erika has 15+ years of experience in the pharmaceutical industry, both within small and larger enterprises. Before she started working at SDS, she held a position as director for global regulatory affairs at a parent company, working with early development, market registrations, and post-approval activities in Europe, the US, and the rest of the world. Furthermore, she has experience in project management of development programs and large business collaborations. Erika holds a Master of Science from Uppsala University and a Ph.D. in bioprocess technology from The Royal Institute of Technology (KTH) in Sweden. Erika's passion is to develop regulatory strategies with the best chance of success for a given product in development.
Christina joined SDS Life Science in 2021 as director for Drug Development. She holds a Master of Science in Pharmacy and a PhD in Pharmaceutics from Uppsala University and has + 20 years of experience in the life science industry. Christina has worked with formulation and product development, process development and manufacturing of most dosage forms from early phase, during registration and life cycle management post-authorization. Previous employments include Senior Scientist within drug development at AstraZeneca and management positions within production, clinical trials, pharmaceutical development and business development at APL as well as the Swedish MPA.
Ulrika Andersson joined SDS Life Science in 2022 as Director of Business Management. She holds a Master of Science in Pharmacy from Uppsala University and has + 25 years of experience in the pharmaceutical industry. Ulrika has worked across all stages of product development from preclinical formulation development to commercial production. Throughout her career, she has focused on project management, commercial management and cross-functional ways of working in a global environment. She joins SDS from a position as Senior Director of Commercial Project Management at a multinational CDMO. Her ambition is to ensure SDS has efficient customer management processes that will support both our staff and our customers so that they can put all their focus on getting new products to the patients.
Susanna joined SDS Life Science in April 2022. She holds a Ph.D. in Clinical Immunology from the Karolinska Institute in Stockholm. Her main research focus has been in the field of respiratory inflammation both from academic research and from the pharmaceutical industry having worked in various positions at AstraZeneca, ALK, Polypeptide and Aqilion.
Her core activities have been focused on project leadership of drug development programs in drug discovery, clinical development and medical affairs, leading global teams of experts and consultants. Susanna has built a deep understanding of the overall drug development and the specific needs and complexity of different development stages. Her main driving force is to support project teams to reach clear decision-making milestones.
Anna is a founder of Scandinavian Development Services (SDS) Group and holds a PhD in Biostatistics from Karolinska Institutet, Stockholm. Her varied experience comes from work within regulatory authorities, the pharmaceutical industry and academic research. She has long-standing industry experience as a consultant within regulatory affairs and drug clinical trials at Pfizer Pharmaceuticals, Pharmacia & Upjohn and Zeneca Pharmaceuticals, to name a few. Anna's expertise lies within clinical development and she is particularly interested in merging statistical and regulatory knowledge to create studies better suited for regulatory needs.
